<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Angelini &#8211; Retail Institute Italy</title>
	<atom:link href="https://www.retailinstitute.it/tag/angelini/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.retailinstitute.it</link>
	<description>Retail Institute Italy</description>
	<lastBuildDate>Fri, 08 Jan 2021 15:26:52 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.5.18</generator>

<image>
	<url>https://www.retailinstitute.it/wp-content/uploads/2019/01/cropped-Favicon_retail-32x32.jpg</url>
	<title>Angelini &#8211; Retail Institute Italy</title>
	<link>https://www.retailinstitute.it</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Farmaceutica, Angelini acquista la svizzera Arvelle per 960 milioni di dollari</title>
		<link>https://www.retailinstitute.it/farmaceutica-angelini-acquista-la-svizzera-arvelle-per-960-milioni-di-dollari/</link>
		
		<dc:creator><![CDATA[vmuti]]></dc:creator>
		<pubDate>Mon, 04 Jan 2021 15:23:40 +0000</pubDate>
				<category><![CDATA[Dal Mondo]]></category>
		<category><![CDATA[News dei Soci]]></category>
		<category><![CDATA[acquisizione]]></category>
		<category><![CDATA[Angelini]]></category>
		<category><![CDATA[Arvelle Therapeutics]]></category>
		<category><![CDATA[Farmaceutica]]></category>
		<category><![CDATA[Svizzera]]></category>
		<guid isPermaLink="false">https://retailinstitute.it/?p=555484</guid>

					<description><![CDATA[<p>Maxi acquisizione in svizzera per Angelini Pharma. L&#8217;azienda farmaceutica italiana ha acquistato la svizzera Arvelle Therapeutics, attiva nei trattamenti per pazienti affetti da disturbi del sistema nervoso centrale. La valutazione &#8230; </p>
<p>L'articolo <a rel="nofollow" href="https://www.retailinstitute.it/farmaceutica-angelini-acquista-la-svizzera-arvelle-per-960-milioni-di-dollari/">Farmaceutica, Angelini acquista la svizzera Arvelle per 960 milioni di dollari</a> proviene da <a rel="nofollow" href="https://www.retailinstitute.it">Retail Institute Italy</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Dal matrimonio tra Angelini Holding e Hero Group nasce MadreNatura</title>
		<link>https://www.retailinstitute.it/dal-matrimonio-tra-angelini-holding-e-hero-group-nasce-madrenatura/</link>
					<comments>https://www.retailinstitute.it/dal-matrimonio-tra-angelini-holding-e-hero-group-nasce-madrenatura/#respond</comments>
		
		<dc:creator><![CDATA[Barbara Mazzarelli]]></dc:creator>
		<pubDate>Wed, 24 Jun 2020 09:57:04 +0000</pubDate>
				<category><![CDATA[News dei Soci]]></category>
		<category><![CDATA[Angelini]]></category>
		<category><![CDATA[baby]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Gruppo Hero]]></category>
		<category><![CDATA[joint-venture]]></category>
		<category><![CDATA[MadreNatura AG]]></category>
		<guid isPermaLink="false">https://retailinstitute.it/?p=550852</guid>

					<description><![CDATA[<p>Angelini Holding, gruppo multinazionale che opera nei settori farmaceutico e beni di consumo, entra nel mercato italiano degli alimenti per l’infanzia in joint venture paritetica con il Gruppo Hero. La &#8230; </p>
<p>L'articolo <a rel="nofollow" href="https://www.retailinstitute.it/dal-matrimonio-tra-angelini-holding-e-hero-group-nasce-madrenatura/">Dal matrimonio tra Angelini Holding e Hero Group nasce MadreNatura</a> proviene da <a rel="nofollow" href="https://www.retailinstitute.it">Retail Institute Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.retailinstitute.it/dal-matrimonio-tra-angelini-holding-e-hero-group-nasce-madrenatura/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Angelini Pharma acquisisce ThermaCare da GSK</title>
		<link>https://www.retailinstitute.it/angelini-pharma-acquisisce-thermacare-da-gsk/</link>
					<comments>https://www.retailinstitute.it/angelini-pharma-acquisisce-thermacare-da-gsk/#respond</comments>
		
		<dc:creator><![CDATA[Barbara Mazzarelli]]></dc:creator>
		<pubDate>Wed, 11 Mar 2020 11:53:07 +0000</pubDate>
				<category><![CDATA[News dei Soci]]></category>
		<category><![CDATA[Angelini]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ThermaCare]]></category>
		<guid isPermaLink="false">https://retailinstitute.it/?p=547967</guid>

					<description><![CDATA[<p>Angelini Pharma annuncia l’acquisizione da GSK dei diritti commerciali di ThermaCare® a livello globale, escluso il Nord America. L’accordo comprende anche il sito produttivo americano dedicato a ThermaCare® ad Albany, &#8230; </p>
<p>L'articolo <a rel="nofollow" href="https://www.retailinstitute.it/angelini-pharma-acquisisce-thermacare-da-gsk/">Angelini Pharma acquisisce ThermaCare da GSK</a> proviene da <a rel="nofollow" href="https://www.retailinstitute.it">Retail Institute Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.retailinstitute.it/angelini-pharma-acquisisce-thermacare-da-gsk/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
